Luo Z, Lin C, Yu C, Yuan C, et al. Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia. Cancer Res 2024 Oct 22. doi: 10.1158/0008-5472.CAN-24-1093.
PMID: 39437162